v3.26.1
Equity - Narrative (Details)
 3 Months Ended
Mar. 31, 2026
USD ($)
$ / shares
shares
Mar. 31, 2025
USD ($)
shares
Dec. 31, 2025
USD ($)
shares
Aug. 31, 2022
shares
Equity [Line Items]        
Authorized amount (in shares)       2,000,000
Average cost per share (in dollars per share) | $ / shares $ 48.70      
Shares remaining available for repurchase (in shares) 968,651      
Unsettled repurchases | $ $ 0      
Preferred shares, convertible preferred, shares outstanding (in shares) 1,935,400   1,935,400  
Preferred shares, liquidation preference | $ $ 96,770,000   $ 96,770,000  
Common Shares        
Equity [Line Items]        
Repurchase of common shares (in shares) 324,586 0    
Preferred shares - Series C        
Equity [Line Items]        
Preferred shares, convertible preferred, shares outstanding (in shares) 1,935,400      
Preferred stock, dividend per annum (in dollars per share) | $ / shares $ 3.25      
Preferred shares, liquidation preference | $ $ 96,770,000      
Convertible preferred stock, conversion ratio (in shares) 0.487      
Preferred stock conversion, threshold conversion price percentage (at least) 1.25      
At-The-Market Program        
Equity [Line Items]        
Sale of stock, authorized amount (up to) | $ $ 350,000,000      
Trustee        
Equity [Line Items]        
Grant date fair value | $ $ 244,000 $ 225,000    
Trustee | Common Shares        
Equity [Line Items]        
Number of shares granted (in shares) 5,085 4,855